ArticleTranslational cancer research2026

Efficacy and safety of programmed cell death protein 1/programmed death-ligand 1 inhibitors combined with chemotherapy for breast cancer: a systematic review and meta-analysis.

Geqiong Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.